Dr. John Noseworthy, the Mayo Clinic chief executive who retired in December, has been named to the board of directors at UnitedHealth Group, the Minnetonka-based company that stands alongside Mayo as one of Minnesota's most prominent health care organizations.
UnitedHealth Group made the announcement Wednesday morning. In a statement, the board's Executive Chairman Stephen Hemsley called Noseworthy "an exceptionally talented and compassionate physician."
Noseworthy already serves on the board of directors for pharmaceutical giant Merck.
At UnitedHealth, he'll be eligible for an annual cash retainer of $125,000 plus annual grants of deferred stock units with an aggregate fair value of about $205,000.
"His leadership has been decisive in Mayo's achievement of consistently high performance in health care quality, safety, research and finance," the statement from Hemsley said.
In nine years as CEO at the Rochester-based clinic, Noseworthy helped Mayo raise more than $3.5 billion in its largest philanthropic campaign as the health care system emerged from the Great Recession on stronger financial footing. Mayo became a focus for statewide economic development during his tenure but also faced tough questions about the cost of its medical services.
The Minneapolis-based nonprofit Minnesota Community Measurement reported again last year that Mayo Clinic in Rochester during 2017 had the highest average total cost of care among all health systems in Minnesota.
Noseworthy and Mayo have strongly rejected the group's methodology, arguing it fails to adequately adjust for the clinic's population of complex patients.